These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9048967)

  • 21. Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.
    Yu XM; Wu YC; Liu X; Huang XC; Hou XX; Wang JL; Cheng XL; Mao WM; Ling ZQ
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of tumor markers and evaluation of their predictive value in patients with colorectal cancer.
    Liu ZP; Li LM; Liu XL; Zhang DX
    Onkologie; 2012; 35(3):108-13. PubMed ID: 22414974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of cytokeratin 20 mRNA in the peripheral blood of patients with colorectal cancer by immunomagnetic bead enrichment and real-time reverse transcriptase-polymeras chain reaction.
    Guo J; Xiao B; Jin Z; Qin L; Chen J; Chen H; Zhang X; Liu Z
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1279-84. PubMed ID: 16048578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of circulating tumor cells by cytokeratin 20 and prostate stem cell antigen RT-PCR in blood of patients with gastrointestinal cancers.
    Lukyanchuk VV; Friess H; Kleeff J; Osinsky SP; Ayuni E; Candinas D; Roggo A
    Anticancer Res; 2003; 23(3B):2711-6. PubMed ID: 12894563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ectopic expression of guanylyl cyclase C in CD34+ progenitor cells in peripheral blood.
    Fava TA; Desnoyers R; Schulz S; Park J; Weinberg D; Mitchell E; Waldman SA
    J Clin Oncol; 2001 Oct; 19(19):3951-9. PubMed ID: 11579116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CK20 gene expression: technical limits for the detection of circulating tumor cells.
    Champelovier P; Mongelard F; Seigneurin D
    Anticancer Res; 1999; 19(3A):2073-8. PubMed ID: 10470150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Significance of detecting disseminated tumor cells in peripheral blood of gastric and colorectal cancer patients].
    Zhang XW; Fan P; Yang HY; Yang L; Chen GY
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):66-9. PubMed ID: 12678992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.
    Yamaguchi K; Takagi Y; Aoki S; Futamura M; Saji S
    Ann Surg; 2000 Jul; 232(1):58-65. PubMed ID: 10862196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correspondence re: B. Molnar et al., Circulating tumor cell clusters in the peripheral blood of colorectal cancer patients. Clin. Cancer Res., 7: 4080-4085, 2001.
    Tsavellas G; Huang A
    Clin Cancer Res; 2002 Jun; 8(6):2015; author reply 2016-7. PubMed ID: 12060648
    [No Abstract]   [Full Text] [Related]  

  • 31. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
    Bostick PJ; Chatterjee S; Chi DD; Huynh KT; Giuliano AE; Cote R; Hoon DS
    J Clin Oncol; 1998 Aug; 16(8):2632-40. PubMed ID: 9704713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detecting circulating cancer cells using reverse transcriptase-polymerase chain reaction for cytokeratin mRNA in peripheral blood from patients with gastric cancer.
    Majima T; Ichikura T; Takayama E; Chochi K; Mochizuki H
    Jpn J Clin Oncol; 2000 Nov; 30(11):499-503. PubMed ID: 11155920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
    Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
    J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Significance of CK20 mRNA expression in peripheral blood of colorectal cancer patients by real-time fluorescent quantitative RT-PCR].
    Xu D; Li XF; Jiang WZ; Cao J; Zheng S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 33(5):403-6. PubMed ID: 15476322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokeratin 20 is not a tissue-specific marker for the detection of malignant epithelial cells in the blood of colorectal cancer patients.
    Bustin SA; Gyselman VG; Siddiqi S; Dorudi S
    Int J Surg Investig; 2000; 2(1):49-57. PubMed ID: 12774338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular detection of cytokeratin-19-positive cells in the peripheral blood of patients with operable breast cancer: evaluation of their prognostic significance.
    Stathopoulou A; Vlachonikolis I; Mavroudis D; Perraki M; Kouroussis Ch; Apostolaki S; Malamos N; Kakolyris S; Kotsakis A; Xenidis N; Reppa D; Georgoulias V
    J Clin Oncol; 2002 Aug; 20(16):3404-12. PubMed ID: 12177100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients.
    Shen C; Hu L; Xia L; Li Y
    Jpn J Clin Oncol; 2008 Nov; 38(11):770-6. PubMed ID: 18845519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of peritoneal micrometastases by reverse transcriptase-polymerase chain reaction targeting carcinoembryonic antigen and cytokeratin 20 in colon cancer patients.
    Aoki S; Takagi Y; Hayakawa M; Yamaguchi K; Futamura M; Kunieda K; Saji S
    J Exp Clin Cancer Res; 2002 Dec; 21(4):555-62. PubMed ID: 12636102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of cytokeratin-20 reverse transcriptase polymerase chain reaction in lymph nodes of node-negative colorectal cancer patients.
    Rosenberg R; Hoos A; Mueller J; Baier P; Stricker D; Werner M; Nekarda H; Siewert JR
    J Clin Oncol; 2002 Feb; 20(4):1049-55. PubMed ID: 11844829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative detection of cytokeratin 20 mRNA expression in bladder carcinoma by real-time reverse transcriptase-polymerase chain reaction.
    Christoph F; Müller M; Schostak M; Soong R; Tabiti K; Miller K
    Urology; 2004 Jul; 64(1):157-61. PubMed ID: 15245962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.